Rémi Rabasa-Lhoret
Institut de Recherches Cliniques de Montreal
16
16
9
N/A
0
10
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+75 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (16)
Showing 10 of 16 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Adrian Vella, MD
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Lisa Porter, MD
Amylin Pharmaceuticals, LLC.
Shared therapeutic areas:
Samuel Klein, MD
Washington University School of Medicine
Shared therapeutic areas:
Laurence Kessler
CHU de Strasbourg
Shared therapeutic areas:
Worked with same sponsors:
Isabelle Durieu
Hospices Civils de Lyon
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Suman Wason, MD
Lexicon Pharmaceuticals, Inc.
Shared therapeutic areas:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Timothy Bailey, MD
AMCR Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (16)
Showing 16 of 16 trials
Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes
Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis
Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training
Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes
Insulin-based Strategies to Prevent Hypoglycemia During Two Types of Exercise
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes
Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes
Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin Therapy
Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes
Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation
Insulin-based Strategies to Prevent Hypoglycemia During Exercise
Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes
Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
Carbohydrates Under Target for Type 1 Diabetes Management
All 16 trials loaded